Literature DB >> 23683098

Objective color classification of ecstasy tablets by hyperspectral imaging.

Gerda Edelman1, Martin Lopatka, Maurice Aalders.   

Abstract

The general procedure followed in the examination of ecstasy tablets for profiling purposes includes a color description, which depends highly on the observers' perception. This study aims to provide objective quantitative color information using visible hyperspectral imaging. Both self-manufactured and illicit tablets, created with different amounts of known colorants were analyzed. We derived reflectance spectra from hyperspectral images of these tablets, and successfully determined the most likely colorant used in the production of all self-manufactured tablets and four of five illicit tablets studied. Upon classification, the concentration of the colorant was estimated using a photon propagation model and a single reference measurement of a tablet of known concentration. The estimated concentrations showed a high correlation with the actual values (R(2) = 0.9374). The achieved color information, combined with other physical and chemical characteristics, can provide a powerful tool for the comparison of tablet seizures, which may reveal their origin.
© 2013 American Academy of Forensic Sciences.

Entities:  

Keywords:  Kubelka-Munk; XTC; color measurement; ecstasy; forensic science; hyperspectral imaging; illicit drugs; tablets

Year:  2013        PMID: 23683098     DOI: 10.1111/1556-4029.12153

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  2 in total

1.  Reflectance-based determination of age and species of blowfly puparia.

Authors:  Sasha C Voss; Paola Magni; Ian Dadour; Christian Nansen
Journal:  Int J Legal Med       Date:  2016-10-21       Impact factor: 2.686

2.  The Historical Face of Narcotic Revisited: A Chinese City's Fifty-Year Quest for Hygienic Modernity, 1900-49.

Authors:  Jianan Huang
Journal:  Med Hist       Date:  2019-01       Impact factor: 1.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.